• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD LABORATORIES, INC BIOPLEX 2200 SYPHILIS TOTAL AND RPR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD LABORATORIES, INC BIOPLEX 2200 SYPHILIS TOTAL AND RPR Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  Injury  
Manufacturer Narrative
A laboratory reported that samples from a patient tested on the bioplex 2200 syphilis total & rpr kit in (b)(6) and (b)(6) 2021 were (b)(6) total and (b)(6) assays. The samples were sent out for confirmatory testing at (b)(6) labs with an elisa syphilis igg assay and at both times, the samples were (b)(6). The physician decided to administer penicillin to the patient based on the bioplex results. However, the physician expressed concern that the bioplex results were (b)(6), while the syphilis igg eia results from (b)(6) were (b)(6).   investigation by the bio-rad product support and technical support found no issues with the instrument. The affected bioplex 2200 syphilis total & rpr, lot 301210 is performing within specification, however, the lot was withdrawn from the market on september 17th because of trends observed in routine stability monitoring that indicate the kit performance will eventually fall below specifications prior to the expiration date. Additionally, bio-rad has recently alerted users that interference can occur in patients who have been recently received the covid-19 vaccine.   vaccine interference is a known limitation for this assay and is already indicated in the labeling.   the vaccination status of the patient is unknown, and the doctor is aware of the potential for increased rpr response due to recent covid-19 vaccination. Per the ifu, test results should be considered with other laboratory results as well as the clinical presentation of the patient. Results should be interpreted by a physician.   the bioplex 2200 syphilis total assay measures both igm and igg antibodies. The method used to confirm at the (b)(6) laboratory only measure igg antibodies. The bioplex 2200 syphilis total results may correctly identified the presence of igm antibodies, however, bio-rad was unable to obtain patient samples for investigation to confirm. Therefore, out of an abundance of caution, and due to concern expressed by the physician, bio-rad is reporting this case as an adverse event for potential unnecessary treatment with penicillin.
 
Event Description
A laboratory reported that samples from a patient tested on the bioplex 2200 syphilis total & rpr kit in (b)(6) and (b)(6) 2021 were (b)(6) total and (b)(6) assays. The samples were sent out for confirmatory testing at (b)(6) labs with an elisa syphilis igg assay and at both times, the samples were (b)(6). The physician decided to administer penicillin to the patient based on the bioplex results. However, the physician expressed concern that the bioplex results were (b)(6), while the (b)(6) results from (b)(6) were (b)(6).  .
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameBIOPLEX 2200 SYPHILIS TOTAL AND RPR
Type of DeviceBIOPLEX 2200 SYPHILIS TOTAL AND RPR
Manufacturer (Section D)
BIO-RAD LABORATORIES, INC
4000 alfred nobel dr
hercules CA 94547
MDR Report Key12602404
MDR Text Key281849281
Report Number1000135116-2021-00002
Device Sequence Number1
Product Code LIP
Combination Product (y/n)N
PMA/PMN Number
K170413
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial
Report Date 10/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Expiration Date02/22/2022
Device Model NumberN/A
Device Catalogue Number12000650
Device Lot Number301210
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received09/08/2021
Is This a Reprocessed and Reused Single-Use Device? No

Patient Treatment Data
Date Received: 10/09/2021 Patient Sequence Number: 1
-
-